Commentary · 8 Jun 2026
Research articlePublished 25 May 2021
Plasma Catecholamines: Blood Molecules Implicated in Alzheimers disease?
1Alzohis Biotechnology Company, Paris, France; 2AP-HP Biological Resources Center “Biobank Lariboisière” BB-0033-00064, INSERM UMR 1141, “NeuroDiderot” Paris University, Lariboisière Hospital, Paris, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Current research highlighted a degeneration of the dopaminergic and noradrenergic systems in the brain, i.e. the ventral tegmental area (VTA) and the locus coeruleus (LC) at an early stage of Alzheimer’s disease (AD), and alterations of catecholamines concentrations in different body fluids (CSF, plasma and urine) of AD patients and animal models. These findings imply a potential utility of catecholamines in the molecular and mechanistic AD comprehension. Following our previous work on plasma noradrenaline in the context of AD, this retrospective study includes a cohort of 105 patients (43 AD, 29 with other dementia and 32 without dementia) from the cognitive neurology center of Lariboisière (Paris) who consulted for memory complaints. We show for the first-time different relations between plasma catecholamines and AD biomarkers at cognitive (MMSE score) and molecular (CSF biomarkers concentrations) levels. Our ROC analyses illustrate the good potential of plasma catecholamines to discriminate AD from non-AD patients with a relatively low or high MMSE score. Taken together, our results support the idea that plasma catecholamines could be blood molecules implicated in AD physiopathology, opening new frontiers in the development of a blood-based AD diagnosis.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Laure-Elise Pillet”
- BylineArticles whose byline prints “Alessandra Gallo”
- BylineArticles whose byline prints “Philippe Manivet”
- BylineArticles whose byline prints “Romain Verpillot”
